Find information on thousands of medical conditions and prescription drugs.

Hepatorenal syndrome

Hepatorenal syndrome (HRS) is liver failure that results in concomitant renal failure. Prognosis is generally very poor. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The renal failure in HRS is thought to result from renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS) activation. Kidneys that are normal typically resume functioning following a successful liver transplantation.

It is estimated that 40% of patients with cirrhosis and ascites, which are stigmata of chronic liver disease, will develop HRS during the course of their disease.

HRS classified in to Type I HRS and Type 2 HRS

  • Type I HRS is associated with spontaneous bacterial peritonitis. Median survival of Type I HRS, without treatment, is less than two weeks.
  • Type II HRS is characterized by relatively stable hepatic function. Survival in Type II HRS is typically 3-6 months.

Treatment

Acute treatment involves maintaining the blood pressure. Several vasoactive agents, including terlipressin, midrodrine and norepinephrine, have shown some benefit. These agents should be given concomitantly with intravenous infusion of albumin. If the patient is taking diuretics, they should be discontinued.

The definitive treatment for HRS is liver transplantation. Transjugular intrahepatic portosystemic shunts (TIPS) and liver dialysis have shown some promise for HRS patients.

Read more at Wikipedia.org


[List your site here Free!]


Orange juice, vitamin C and [F.sub.2]-isoprostanes - Vitamins and Minerals
From Nutrition Research Newsletter, 10/1/03

An increased consumption of fruit and vegetables has been associated with beneficial effects on the risk of disease. Citrus juices, especially orange juice and grapefruit juice, are rich sources of vitamin C. Recent reports suggest that drinking generous amounts of a mixture of juices improved the blood lipid profile, reduced oxidative stress, prevented atherogenic modifications of LDL cholesterol and platelet aggregation and improved HDL-cholesterol levels. However, no study has examined the bioavailability of vitamin C in orange juice and its possible beneficial effects on reducing isoprostane levels.

Isoprostanes are a family of eicosanoids of nonenzymatic origin that are produced by the random oxidation of phospholipids by oxygen radicals and that are elevated by oxidative stress. One of the isoprostanes, 8-epiprostaglandin F2 (8-epi-PG[F.sub.2[alpha]]) has been shown to act as a vasoconstrictor and are associated with the hepatorenal syndrome and pulmonary oxygen toxicity. Previous studies have showed decreased concentration of antioxidants and high concentrations of 8-isoprostanes among smokers, which may be due to a low level of antioxidants or a greater utilization of vitamin C by free radicals produced during smoking. Therefore, a recent study published in the American Journal of Clinical Nutrition assessed the bioavailability of vitamin C in orange juice and its effect on concentrations of 8-epi-PG[F.sub.2[alpha]] (F2-isoprostanes) in a healthy human population.

Six men and six women were enrolled in this study. The vitamin C bioavailability study was divided into two components, a dose-response test and a multiple-dose-response study. The subjects consumed 500 mL commercial fresh-squeezed orange juice per day for 14 days, corresponding to an intake of 250 mg ascorbic acid/day. On the first day of the study, the subjects drank the juice in one dose (dose-response study) and on days two and 14 they consumed 250 mL in the morning and 250 mL in the afternoon. Blood was collected every hour for six hours on the first day and again on days seven and 14. Dietary history data were obtained through a food-frequency questionnaire.

Baseline plasma vitamin C levels were significantly higher in the women than in the men. In the dose-response study, the maximum increase in plasma vitamin C occurred three hours postdose in all of the subjects. Vitamin C concentrations remained significantly higher on days seven and 14 than at baseline. Baseline concentrations of 8-epi-PG[F.sub.2[alpha]] were significantly higher among the men than the women, but decreased significantly by day 14 of the intervention. A significant inverse correlation was observed between vitamin C and 8-epi-PG[F.sub.2[alpha]] at baseline and on day 14 of the study. Among smokers, baseline vitamin C was lower, and 8-epi-PG[F.sub.2[alpha]] higher than among non-smokers.

The results showed that drinking two glasses of orange juice daily increases plasma vitamin C levels by 40% to 64%. Interestingly, changes in vitamin C levels were significantly and inversely correlated, with concentrations of 8-epi-PG[F.sub.2[alpha]] suggesting that vitamin C may play a critical role in reducing the formation of compounds produced by the random oxidation of phospholipids by oxygen radicals. These effects were accentuated among smokers than among non-smokers. This suggests that the protective effects of vitamin C is greater in persons with higher stress and that higher concentrations of vitamin C in tissues can be gained by drinking orange juice daily. Further research on the health-promoting properties of vitamin C in fruit is necessary.

Concepcion Sanchez-Moreno, Pilar Cano, Begona de Ancos, et al., Effect of Orange Juice Intake on Vitamin C Concentrations and Biomarkers of Antioxidant Status in Humans, Am J Clin Nutr 78: 454-460 (September 2003). [Address reprint requests to A Martin, Nutrition and Neurocognitive Laboratory, Jean Mayer USDA-HNRC on Aging At Tufts University, 711 Washington Street, 7th Floor, Boston, MA 02111. E-mail: antonio.martin@tufts.edu]

COPYRIGHT 2003 Frost & Sullivan
COPYRIGHT 2003 Gale Group

Return to Hepatorenal syndrome
Home Contact Resources Exchange Links ebay